PL437901A1 - Probówka do wytwarzania fibryny bogatopłytkowej oraz sposób wytwarzania fibryny bogatopłytkowej - Google Patents

Probówka do wytwarzania fibryny bogatopłytkowej oraz sposób wytwarzania fibryny bogatopłytkowej

Info

Publication number
PL437901A1
PL437901A1 PL437901A PL43790121A PL437901A1 PL 437901 A1 PL437901 A1 PL 437901A1 PL 437901 A PL437901 A PL 437901A PL 43790121 A PL43790121 A PL 43790121A PL 437901 A1 PL437901 A1 PL 437901A1
Authority
PL
Poland
Prior art keywords
rich fibrin
producing platelet
platelet
test tube
producing
Prior art date
Application number
PL437901A
Other languages
English (en)
Other versions
PL249414B1 (pl
Inventor
Łukasz Pałka
Original Assignee
Łukasz Pałka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Łukasz Pałka filed Critical Łukasz Pałka
Priority to PL437901A priority Critical patent/PL249414B1/pl
Publication of PL437901A1 publication Critical patent/PL437901A1/pl
Publication of PL249414B1 publication Critical patent/PL249414B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5002—Partitioning blood components

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Wynalazek dotyczy probówki do wytwarzania fibryny bogatopłytkowej (PRF) zawierającej czynniki wspomagające krzepnięcie krwi, znajdującej zastosowanie w medycynie regeneracyjnej i estetycznej oraz w chirurgii stomatologicznej, która zawiera mieszaninę izolowanego lub rekombinowanego ludzkiego czynnika von Willebranda (VWF) oraz izolowanego lub rekombinowanego ludzkiego czynnika VIII krzepnięcia (FVIII) użytych w proporcji 1 : 1-2. Przedmiotem wynalazku jest również sposób wytwarzania fibryny bogatopłytkowej (PRF).
PL437901A 2021-05-19 2021-05-19 Sposób wytwarzania fibryny bogatopłytkowej PL249414B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL437901A PL249414B1 (pl) 2021-05-19 2021-05-19 Sposób wytwarzania fibryny bogatopłytkowej

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL437901A PL249414B1 (pl) 2021-05-19 2021-05-19 Sposób wytwarzania fibryny bogatopłytkowej

Publications (2)

Publication Number Publication Date
PL437901A1 true PL437901A1 (pl) 2022-11-21
PL249414B1 PL249414B1 (pl) 2026-04-13

Family

ID=84191890

Family Applications (1)

Application Number Title Priority Date Filing Date
PL437901A PL249414B1 (pl) 2021-05-19 2021-05-19 Sposób wytwarzania fibryny bogatopłytkowej

Country Status (1)

Country Link
PL (1) PL249414B1 (pl)

Also Published As

Publication number Publication date
PL249414B1 (pl) 2026-04-13

Similar Documents

Publication Publication Date Title
Afat et al. Effects of leukocyte-and platelet-rich fibrin alone and combined with hyaluronic acid on early soft tissue healing after surgical extraction of impacted mandibular third molars: A prospective clinical study
Schramm The history of haemophilia–a short review
Giannini et al. Comparison between PRP, PRGF and PRF: lights and shadows in three similar but different protocols
Athanasiadis et al. Effects of topical antifibrinolytics in endoscopic sinus surgery: a pilot randomized controlled trial
ATE442373T1 (de) Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden
Schmugge et al. Platelets and von Willebrand factor
GRALNICK et al. Platelet von Willebrand factor
Taschieri et al. Short implants in maxillary and mandibular rehabilitations: interim results (6 to 42 months) of a prospective study
CO2023017358A2 (es) Formulaciones de proteínas quiméricas del factor viii y usos de las mismas
Pfueller et al. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome
WO2023172893A3 (en) Methods of treating hemophilia a
Sugita et al. Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions
Vermylen et al. Evidence that ‘activated’prothrombin concentrates enhance platelet coagulant activity
Bermudez et al. Management of inherited, acquired, and iatrogenically induced coagulopathies in oral surgery
Simson et al. Clinical evaluation of cryoprecipitated factor VIII
Green Hemophilia and von Willebrand disease: Factor VIII and von Willebrand Factor
MX2024004494A (es) Formulaciones de proteinas quimericas de factor viii y usos de las mismas.
Findik et al. Secondary closure of alveolar clefts with mandibular symphyseal bone grafts and with platelet-rich fibrin under local anesthesia: three case reports
Singh et al. Profile changes after conventional and chin shield genioplasty
Singha et al. Evaluation of treatment outcome after impacted mandibular third molar surgery with and without autologous platelet concentrates
Harfoush et al. Evaluation of topical application of platelet rich fibrin (PRF) in homeostasis of the bleeding after teeth extraction in patients taking warfarin
Aprajita Guided bone regeneration using a platelet-rich fibrin membrane and sticky bone graft along with implant placement in maxillary anterior region: a case report
Burton et al. Proplast grafting: A new method for stabilization of maxillary advancements
Storti et al. Epsilon-aminocaproic acid for synovectomy in haemophilic patients
Stephen et al. Assessment of knowledge, awareness, and perception of platelet-rich plasma among oral surgeons